Live
- G20 Leaders Will Talk About Climate, Taxes, and Trump's Return in Brazil
- COP29: CDRI announces $8 million funding for 12 projects to address climate crisis
- Anti-Telgu remarks: Actor Kasthuri Shankar moves court for bail
- Samsung AR Smart Glasses Set to Launch in 2025, Featuring Ray-Ban Meta-Like Design
- Kerala Industries Minister confident that new policy will boost plantation sector
- Madras HC plans inter-departmental monitoring committee to combat drug use in TN
- Bihar: Spotted deer dies due to heart attack in Banka district
- Mushtaq Ali T20: Shami to spearhead Bengal bowling attack, Gharami named captain
- Kharge's clarion call to oust Maharashtra's BJP-backed MahaYuti
- Why Ukraine’s Use of US Missiles Against Russia Could Lead to World War 3
New Delhi: Centre cancels Chinese test kit orders
Not a single rupee will be lost to Chinese firms who provided 5 lakh faulty COVID-19 test kits to India as the orders have been cancelled and the payments not made, the government said on Monday amid a controversy over the issue
New Delhi: Not a single rupee will be lost to Chinese firms who provided 5 lakh faulty COVID-19 test kits to India as the orders have been cancelled and the payments not made, the government said on Monday amid a controversy over the issue.
Several states, including Rajasthan and West Bengal complained about the new test kits, saying they had only 5.4 per cent accuracy. Opposition parties questioned the government's purchase as well.
Coronavirus test kits made by two Chinese companies Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics have been found "under-performing" by the Indian Council of Medical Research (ICMR), the government said.
It has asked states and hospitals to stop using the kits made by the two companies and since "due process followed (not going for procurement with 100% advance amount), GoI (Government of India) does not stand to lose a single rupee", an official statement said.
16 districts in the country which earlier had cases have not reported any fresh cases since last 28 days. A total of 85 districts from 25 states and UTs have not reported any fresh coronavirus case in last 14 days.
Stigma associated with COVID-19 should be addressed through an intensive campaign. "We have to understand that there is no risk of transmission from recovered patients. They, in fact, can be a potential source of healing for antibodies using plasma therapy, said an ICMR official.
"We should avoid spreading misinformation and panic. No community or area should be labelled for COVID19 spread. In particular, healthcare and sanitary workers or police should not be targeted as they are there to help you."
